Suzanne Cosgrove

	Website What We Do Who We Are Careers

Become a sponsor »

Suzanne Cosgrove Occupation Director of Corporate Communications Employer Cboe Global Markets Location Chicago Twitter @srcosgrove LinkedIn Profile Website www.cboe.com Suzanne Cosgrove is director of corporate communications at Cboe Global Markets. She is a longtime journalist and adjunct professor of journalism. Before joining the Cboe, she was a freelance editor, writer and educator. She was a writer and editor for Cosgrove Communications and a contributing writer with Market News International. She is an adjunct professor of journalism at Northwestern University. She is a member of the Tribune un-linked group. Background Cosgrove worked as a financial editor at the Chicago Tribune from 2000 through 2009. She has been an adjunct professor at Northwestern University’s Medill School of Journalism and freelanced as an editor and writer on a variety of topics, including finance, markets and real estate. Also previously, she served as Market News International’s Chicago bureau chief and covered the Chicago futures markets, banking and economics for Knight-Ridder Financial News. Education She holds a master’s degree in journalism from Medill and a bachelor’s degree from Loyola University/Mundelein College. References

JLN News Feed The Spread – Getting Pronged: A Volcker Rule Update UBS Deribit Central Bank Decisions, Not G7, Seize Options Traders’ Attention; UBS Faces Backlash Over Options Strategy Sponsor News Delisting of Securities of iPic Entertainment Inc., Ultra Petroleum Corp., and Warrant of Repay Holdings Corporation from The Nasdaq Stock Market Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2019 CME Group Declares Quarterly Dividend Nasdaq July 2019 Volumes Confidence in the ag economy soars; producers confirm large prevented plantings of corn and soybeans We visit more than 100 websites daily for financial news (Would YOU do that?). Read the John Lothian Newsletter. FREE 90 day trial